Toxys is a Dutch biotech company specializing in innovative in vitro toxicity screening solutions. Their primary goal is to provide essential information to clients, helping them make informed decisions during the development of new compounds, particularly in the pharmaceutical, chemical, cosmetics, and food industries. By focusing on reducing animal testing, Toxys contributes to the creation of safer products and more efficient drug development processes.

Key Services and Assays

ToxTracker®: This high-throughput, stem cell-based reporter assay identifies carcinogenic hazards by detecting the activation of specific cellular signaling pathways. It is particularly useful for distinguishing between DNA damage, oxidative stress, protein damage, and general cellular stress, thus providing valuable mechanistic insights.

ReproTracker®: This assay focuses on identifying developmental toxicity, aiding in the early detection of teratogenic risks associated with new compounds.

ToxProfiler™: This assay offers a comprehensive toxicity profile of compounds, useful in various stages of product development.

Focus Areas

• Genetic Toxicology: Using tools like ToxTracker to detect and understand genotoxic compounds.
• Developmental Toxicology: Including ReproTracker for assessing developmental risks.
• Mechanistic Toxicology: Offering detailed insights into the mechanisms of toxicity.

Company Highlights

• Expertise: Toxys is recognized internationally for its scientific expertise, providing high-quality, reliable results.
• Regulatory Alignment: They work closely with regulatory agencies to support dossier building and decision-making, ensuring compliance and safety.
• Innovation and Ethics: The company is committed to reducing animal testing by providing advanced in vitro models that offer reliable insights into the mechanisms of action of novel chemicals.

Website: https://toxys.com/ 

Email: info@toxys.com